US2016200689A1PendingUtilityA1

Delta opioid receptor agonist compounds

Assignee: VERSI GROUP LLCPriority: Oct 29, 2001Filed: Mar 23, 2016Published: Jul 14, 2016

Est. expiryOct 29, 2021(expired)· nominal 20-yr term from priority

Inventors:Kwen-Jen Chang Klim King Kestutis P. Biciunas Robert W. Mcnutt, Jr.William Pendergast Shyi-Tai Jan

A61K 31/00A61P 15/00C07D 241/04A61K 31/519A61K 38/33A61P 15/10A61K 31/495A61K 31/445

PatentIndex Score

Cited by

References

Claims

Abstract

Compositions and methods for treatment of sexual dysfunctions by administering to a subject a pharmaceutical composition comprising a delta opioid receptor agonist in an amount effective to delay the onset of ejaculation in the subject during sexual stimulation.

Claims

exact text as granted — not AI-modified

What is claimed is: 
     
         1 . A delta opioid receptor agonist compound having the following structure: 
       
         
           
           
               
               
           
         
         4-((alpha-R)-alpha-((2S,5R)-2,5-Dimethyl-4-(4-fluorobenzyl)-1-piperazinyl)-3-hydroxybenzyl)-N,N-diethylbenzamide 
       
     
     
         2 . The delta opioid receptor agonist compound of  claim 1  wherein the compound is combined with a pharmaceutically acceptable solution.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.